Mohamad Zamani-Ahmadmahmudi
Overview
Explore the profile of Mohamad Zamani-Ahmadmahmudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zamani-Ahmadmahmudi M, Jajarmi M, Talebipour S
Vet Comp Oncol
. 2022 Oct;
21(1):73-81.
PMID: 36251017
Canine mammary gland tumours (CMTs) constitute the most common cancer in female dogs and comprise approximately 50% of all canine cancers. With the advent of high-throughput technologies such as microarray...
2.
Zamani-Ahmadmahmudi M, Nassiri S, Asadabadi A
Sci Rep
. 2021 Oct;
11(1):21098.
PMID: 34702929
Gene expression profiling has been vastly used to extract the genes that can predict the clinical outcome in patients with diverse cancers, including diffuse large B-cell lymphoma (DLBCL). With the...
3.
Babazadeh S, Nassiri S, Siavashi V, Sahlabadi M, Hajinasrollah M, Zamani-Ahmadmahmudi M
Cell Mol Biol Lett
. 2021 Jun;
26(1):30.
PMID: 34174813
Background: Phenotypic and functional heterogeneity of macrophages is known to be the main reason for their ability to regulate inflammation and promote tumorigenesis. Mesenchymal stem cells (MSCs) are one of...
4.
Zamani-Ahmadmahmudi M, Nassiri S, Soltaninezhad F
Br J Haematol
. 2020 May;
192(2):310-321.
PMID: 32410217
Several prognostic gene signatures have been developed to predict the clinical outcome in patients with multiple myeloma (MM). The most salient disadvantage of the previous signatures is their non-reproducibility in...
5.
Abdollahi-Pirbazari M, Jamshidi S, Nassiri S, Zamani-Ahmadmahmudi M
BMC Vet Res
. 2019 Dec;
15(1):460.
PMID: 31856815
Background: Feline leukemia virus (FeLV) is a serious viral infection in cats. FeLV is found in some tissues, such as spleen, lymph nodes and epithelial tissues. However, there is controversy...
6.
Zamani-Ahmadmahmudi M, Nassiri S
Sci Rep
. 2019 Aug;
9(1):12198.
PMID: 31434961
Alongside various clinical prognostic factors for diffuse large B-cell lymphoma (DLBCL) such as the international prognostic index (IPI) components (ie, age, tumor stage, performance status, serum lactate dehydrogenase concentration, and...
7.
Hekmatynia F, Eskandarzadeh N, Imani M, Rezaei M, Zamani-Ahmadmahmudi M
BMC Vet Res
. 2019 Jul;
15(1):242.
PMID: 31300054
Background: Urinalysis is a critical diagnostic test which is performed in routine veterinary medicine practice. In this diagnostic test, semiquantitative measurement of urine biochemical substances is carried out using urinary...
8.
Zamani-Ahmadmahmudi M, Dabiri S, Nadimi N
Transl Res
. 2017 May;
185:47-57.
PMID: 28549851
Molecular profiling is used to extract prognostic gene signatures in different cancers such as multiple myeloma (MM), which is the second most common hematological malignancy. In this study, we utilized...
9.
Siavashi V, Asadian S, Taheri-Asl M, Keshavarz S, Zamani-Ahmadmahmudi M, Nassiri S
J Cell Biochem
. 2017 Mar;
118(10):3299-3307.
PMID: 28294401
Microvascular dysfunction plays a key role in the pathology of sepsis, leading to multi-organ failure, and death. Circulating endothelial progenitor cells (cEPCs) are critically involved in the maintenance of the...
10.
Zamani-Ahmadmahmudi M, Aghasharif S, Ilbeigi K
BMC Vet Res
. 2017 Jan;
13(1):17.
PMID: 28069005
Background: Canine B-cell lymphoma is deemed an ideal model of human non-Hodgkin's lymphoma where the lymphomas of both species share similar clinical features and biological behaviors. However there are some...